Zhongwen Luo
- Topics
- Ubiquitin and proteasome pathways (5 papers)Protein Degradation and Inhibitors (4 papers)Peptidase Inhibition and Analysis (4 papers)
- Journals
- Proceedings of the National Academy of SciencesFree Radical Biology and MedicineJournal of Medicinal Chemistry
- Partner nations
- ChinaUnited States
In The Last Decade
Zhongwen Luo
23 papers receiving 398 citations
Hit Papers
Peers
Comparison fields: 5 of 79
- Molecular Biology 267
- Pharmacology 52
- Organic Chemistry 42
- Cancer Research 41
- Pharmacology 40
Countries citing papers authored by Zhongwen Luo
This map shows the geographic impact of Zhongwen Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhongwen Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhongwen Luo more than expected).
Fields of papers citing papers by Zhongwen Luo
This network shows the impact of papers produced by Zhongwen Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhongwen Luo. The network helps show where Zhongwen Luo may publish in the future.
Co-authorship network of co-authors of Zhongwen Luo
This figure shows the co-authorship network connecting the top 25 collaborators of Zhongwen Luo. A scholar is included among the top collaborators of Zhongwen Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhongwen Luo. Zhongwen Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 6 | |
| 5 | Progress in approved drugs from natural product resourcesbreakdown → | 145 |
| 6 | 11 | |
| 7 | 6 | |
| 8 | 9 | |
| 9 | 4 | |
| 10 | 38 | |
| 11 | 16 | |
| 12 | 25 | |
| 13 | 24 | |
| 14 | 11 | |
| 15 | 32 | |
| 16 | 1 | |
| 17 | 6 | |
| 18 | 3 | |
| 19 | 24 | |
| 20 | 23 |
About Zhongwen Luo
Zhongwen Luo is a scholar working on Parasitology, Oncology and Molecular Biology, having authored 24 papers that have together received 403 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (5 papers), Protein Degradation and Inhibitors (4 papers) and Peptidase Inhibition and Analysis (4 papers). The work is most often cited by research in Toxicology (16 citations), Pharmacology (40 citations) and Complementary and alternative medicine (33 citations). Zhongwen Luo has collaborated with scholars based in China and United States. Frequent co-authors include Fucheng Yin, Lingyi Kong, Xiaobing Wang, Shang Li, Heng Luo, Xinye Chen, Dehua Lu, Lailiang Qu, Xingchen Liu and Yonglei Zhang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Free Radical Biology and Medicine and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.